Abstract:

Objective To observe the clinical value for diagnosing Cerebral Cysticercosis by detecting serum cysticercus IgG antibody. Methods The cysticercus IgG antibody in serum of 1226 clinically diagnosed Cerebral Cysticercosis cases was detected and analyzed. Results Of 1226 Cerebral Cysticercosis cases, the cysticercus IgG antibody of 689 cases was positive and the positive rate was 54.4%. Of 685 acute cases and 476 chronic cases, the number of positive cases was 436 (63.7%) and 173 (36.3%), respectively. The two positiverates had significant difference (χ2=84.0, P<0.01). Of 520 acute cases with single lesions and 165 cases with
multiple lesions, the number of positive cases was 295 (56.7%) and 141 (85.5%), respectively. The two positive rates had significant difference (χ2=44.7, P<0.01). Of 385 chronic cases with single lesions and 91 cases with multiple lesions, the number of positive cases was 126 (32.7%) and 47 (51.7%), respectively. The two positive rates had significant difference (χ2=11.5, P<0.01). Of 98 cases with acute and chronic lesions and 7 cases with diffuse lesions, the number of positive cases was 73 (74.5%) and 7 (100%), respectively. Conclusion The cysticercus IgG antibody positive rate of the acute Cerebral Cysticercosis cases is higher than that of the chronic cases. The positive rate of the cases with multiple lesions is higher than that of the cases with single lesions.

Key words: Cerebral Cysticercosis, Cysticercus IgG antibody, Serum